Lewes, DE -- (SBWIRE) -- 09/23/2016 -- Human Papillomavirus Protein E6 – Pipeline Review, H2 2016; Human Papillomavirus Protein E6 (E6) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by Companies and remaining by the Universities/Institutes.

Furthermore, Human Papillomavirus Protein E6 (E6) The Human Papillomavirus (HPV) E6 protein is one of oncoproteins encoded by the virus. It is a 151 amino-acid peptide. It plays a major role in the induction and maintenance of cellular transformation. It acts mainly as an oncoprotein by stimulating the destruction of many host cell key regulatory proteins. The complex E6/E6P targets several other substrates to degradation via the proteasome including host NFX1-91. The resulting increased expression of hTERT prevents the shortening of telomere length leading to cell immortalization.

The report 'Human Papillomavirus Protein E6 – Pipeline Review, H2 2016' outlays comprehensive information on the Human Papillomavirus Protein E6 (E6) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

It also reviews key players involved in Human Papillomavirus Protein E6 (E6) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases. Currently, The molecules developed by Companies in Phase II, Phase I and Preclinical stages are 5, 2 and 5 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 1 and 1 molecules, respectively.

For more information Visit at: http://www.marketresearchreports.com/global-markets-direct/human-papillomavirus-protein-e6-e6-pipeline-review-h2-2016

Related Reports;

Plasminogen (Plasmin or PLG or EC 3.4.21.7) - Pipeline Review, H2 2016 - http://www.marketresearchreports.com/global-markets-direct/plasminogen-plasmin-or-plg-or-ec-34217-pipeline-review-h2-2016

Beta Secretase 1 (Aspartyl Protease 2 or Beta Site Amyloid Precursor Protein Cleaving Enzyme 1 or Memapsin 2 or Membrane Associated Aspartic Protease 2 or BACE1 or EC 3.4.23.46) - Pipeline Review, H2 2016 - Visit at - http://www.marketresearchreports.com/global-markets-direct/beta-secretase-1-aspartyl-protease-2-or-beta-site-amyloid-precursor-protein

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016 - Visit at - http://www.marketresearchreports.com/global-markets-direct/interleukin-1-beta-il-1-beta-or-catabolin-or-il1b-pipeline-review-h2-2016

Transforming Growth Factor Beta 1 (TGFB1) - Pipeline Review, H2 2016 - Visit at - http://www.marketresearchreports.com/global-markets-direct/transforming-growth-factor-beta-1-tgfb1-pipeline-review-h2-2016

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions